Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis-Reference-Cited by-同舟云学术

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis

Published:2009-08-31 Issue:44 Volume:28 Page:3866-3879
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Seckinger A,Meißner T,Moreaux J,Goldschmidt H,Fuhler G M,Benner A,Hundemer M,Rème T,Shaughnessy J D,Barlogie B,Bertsch U,Hillengass J,Ho A D,Pantesco V,Jauch A,De Vos J,Rossi J F,Möhler T,Klein B,Hose D

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2009257.pdf

Reference46 articles.

1. Barlogie B, Tricot G, Rasmussen E, Anaissie E, van RF, Zangari M et al. (2006). Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies. Blood 107: 2633–2638.

2. Blade J, Samson D, Reece D, Apperley J, Bjorkstrand B, Gahrton G et al. (1998). Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 102: 1115–1123.

3. Caplan AI . (2007). Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213: 341–347.

4. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L et al. (2003). Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A: 1544–1552.

5. Clement JH, Sanger J, Hoffken K . (1999). Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor. Int J Cancer 80: 250–256.

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation;JCO Precision Oncology;2024-07

2. RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma;Frontiers in Immunology;2023-11-15

3. Identification of NOTCH-driven matrisome-associated genes as prognostic indicators of multiple myeloma patient survival;Blood Cancer Journal;2023-09-05

4. NORAD promotes multiple myeloma cell progression via BMP6/P-ERK1/2 axis;Cellular Signalling;2022-12

5. A functional three‐dimensional microphysiological human model of myeloma bone disease;Journal of Bone and Mineral Research;2021-07-27